ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial.

Paolo Antonio Ascierto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.